Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00922584
Recruitment Status : Completed
First Posted : June 17, 2009
Last Update Posted : August 21, 2013
Information provided by (Responsible Party):
Yi-Long Wu, Chinese Society of Lung Cancer